These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24903689)

  • 21. Improved allocation of costs through analysis of variation in data: planning of laboratory studies.
    Foster TA; Asztalos BF
    Clin Chim Acta; 2001 Dec; 314(1-2):55-66. PubMed ID: 11718679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample-size determination for the Bayesian t test and Welch's test using the approximate adjusted fractional Bayes factor.
    Fu Q; Hoijtink H; Moerbeek M
    Behav Res Methods; 2021 Feb; 53(1):139-152. PubMed ID: 32632740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using information from network meta-analyses to optimize the power and sample allocation of a subsequent trial with a new treatment.
    Hu D; Wang C; Ye F; O'Connor AM
    BMC Med Res Methodol; 2022 Nov; 22(1):299. PubMed ID: 36418960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimum sample size determination in stratified case-control studies with cost considerations.
    Nam JM; Fears TR
    Stat Med; 1992 Feb; 11(4):547-56. PubMed ID: 1609184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On sample size calculation for 2x2 fixed-effect ANOVA when variances are unknown and possibly unequal.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):417-25. PubMed ID: 18559139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Betamax: towards optimal sampling strategies for high-throughput screens.
    Grover D; Nunez-Iglesias J
    J Comput Biol; 2012 Jun; 19(6):776-84. PubMed ID: 22697247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical efficiency in multiple-to-one comparison trials with optimal allocation ratio.
    Zhang J; Zhang JJ
    J Biopharm Stat; 2011 Jan; 21(1):125-35. PubMed ID: 21191859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple procedure to compute the sample size needed to compare two independent groups when the population variances are unequal.
    Singer J
    Stat Med; 2001 Apr; 20(7):1089-95. PubMed ID: 11276038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extending the CLAST sequential rule to one-way ANOVA under group sampling.
    Ximénez C; Revuelta J
    Behav Res Methods; 2007 Feb; 39(1):86-100. PubMed ID: 17552475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Power and sample size calculations for comparison of two regression lines with heterogeneous variances.
    Shieh G
    PLoS One; 2018; 13(12):e0207745. PubMed ID: 30557387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Power and sample size calculations for Mendelian randomization studies using one genetic instrument.
    Freeman G; Cowling BJ; Schooling CM
    Int J Epidemiol; 2013 Aug; 42(4):1157-63. PubMed ID: 23934314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing the stages of hospital cost accounting.
    Young DW; Pearlman LK
    Healthc Financ Manage; 1993 Apr; 47(4):58, 60, 63-4 passim. PubMed ID: 10145792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Step-down trend tests for identifying the minimum effective dose.
    Amaratunga D; Ge N
    J Biopharm Stat; 1998 Mar; 8(1):151-62. PubMed ID: 9547433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The variable-criteria sequential stopping rule: generality to unequal sample sizes, unequal variances, or to large ANOVAs.
    Fitts DA
    Behav Res Methods; 2010 Nov; 42(4):918-29. PubMed ID: 21139159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some thoughts on sample size: a Bayesian-frequentist hybrid approach.
    Gordon Lan KK; Wittes JT
    Clin Trials; 2012 Oct; 9(5):561-9. PubMed ID: 22865839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials.
    Chen H; Zhang N; Lu X; Chen S
    Clin Trials; 2013 Aug; 10(4):522-9. PubMed ID: 23794405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable criteria sequential stopping rule: Validity and power with repeated measures ANOVA, multiple correlation, MANOVA and relation to Chi-square distribution.
    Fitts DA
    Behav Res Methods; 2018 Oct; 50(5):1988-2003. PubMed ID: 28936614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resource measurement by health care providers.
    Suver JD; Neumann BR
    Hosp Health Serv Adm; 1986; 31(5):44-52. PubMed ID: 10280908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.